EPISODE · Mar 30, 2022 · 19 MIN
Steroids, Dyspnea, and COVID: Clinical Challenges in COPD Management
from ePulmonology Review
In early 2022, the state of the art for managing patients with COPD continues to present challenges. When, how, and in whom are inhaled steroids the most effective way to reduce exacerbations? Are the GOLD guidelines still relevant? What do patients with COPD need to know about the dangers and long-term effects of COVID-19 infection? These are some of the questions we discuss with our guest, Dr. Nirupama Putcha from the Division of Pulmonology and Critical Care at the Johns Hopkins University School of Medicine, in this issue of ePulmonology Review. Take our post-test to claim CME credits. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
In early 2022, the state of the art for managing patients with COPD continues to present challenges. When, how, and in whom are inhaled steroids the most effective way to reduce exacerbations? Are the GOLD guidelines still relevant? What do patients with COPD need to know about the dangers and long-term effects of COVID-19 infection? These are some of the questions we discuss with our guest, Dr. Nirupama Putcha from the Division of Pulmonology and Critical Care at the Johns Hopkins University School of Medicine, in this issue of ePulmonology Review. Take our post-test to claim CME credits. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Steroids, Dyspnea, and COVID: Clinical Challenges in COPD Management
No transcript for this episode yet
Similar Episodes
Mar 5, 2026 ·8m
Jan 28, 2026 ·33m
Jan 23, 2026 ·36m
Aug 6, 2025 ·15m
Feb 25, 2025 ·16m